Dear Colleagues and Friends,

  The Organizers, consisting of:
    - Mossakowski Medical Research Institite, Polish Academy of Sciences
    - The Committee on Neurobiology of the Polish Academy of Sciences
    - Nalecz Institute of Biocybernetics and Biomedical Engineering, Polish Academy of Sciences

    
is pleased to invite you to the 17th International Symposium "Molecular Basis of Pathology and Therapy in Neurological Disorders" which will take place on 15 - 16 October 2026 at the Conference Center of the Nalecz Institute of Biocybernetics and Biomedical Engineering in Warsaw, Ks. Trojdena 4 st.

The program includes 4 thematic sessions and 2 poster presentation sessions. Abstracts of the short oral presentations and posters will be published in Folia Neuropathologica journal.

Session topics :
- Advancing Human Neural Models: From Organoids to Physiologically Relevant Systems
- Glial cells in neurodevelopmental and neurodegenerative diseases
- Novel aspects of calcium signaling in the Central Nervous System
- Neurodegenerative and Neuromuscular Diseases: From Molecular Mechanisms to Pathophysiology

The following speakers have confirmed their participation in the conference:

• Laura Batlle Morera (Centre for Genomic Regulation, CRG, Barcelona, Spain)
• Ira Espuny-Camacho(University of Liège, Liège, Belgium)
• Leonora Buzanska (Department of Stem Cell Bioengineering, , Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland)
• Katarzyna Tokarska (The Centre for Advanced Materials and Technologies CEZAMAT, Warsaw University of Technology, Warsaw, Poland)
• Michal K. Stachowiak (University at Buffalo, Buffalo, USA)
• Maurice Whelan (European Commission Joint Research Centre, JCR, Ispra, Italy)
• Julien Puyal (Department of Fundamental Neurosciences, University of Lausanne, Lausanne Switzerland)
• Anna Malik (Faculty of Biology, University of Warsaw, Warsaw, Poland)
• Sujith Sajja (The Geneva Foundation,Bethesda, Maryland, USA)
• Amit Srivastava (Thomas Jefferson University, Philadelphia, USA)
• Francesco Moccia (Department of Medicine and Health Sciences University of Molise, Campobasso,Italy)
• Urszula Wojda (Head of Laboratory of Preclinical Testing of Higher Standard
• Neurobiology Center, Nencki Institute of Experimental Biology, Warsaw, Poland)
• Karolina Pircs (HCEMM-SU Neurobiology and Neurodegenerative Diseases Research Group Institute of Clinical Pathophysiology Semmelweis University Budapest, Budapest, Hungary)
• Tito Calì (Department of Biomedical Sciences University of Padova, Padova, Italy)
• Martin Heine(Institute of Developmental and Neurobiology (iDN) Functional Neurobiology; Johannes Gutenberg-University, Mainz, Germany)
• Silvia V. Conde, (NOVA Medical School, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Lisbon, Portugal)
• Pawel Grieb, (Farmacology Department Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland)
• Magdalena Czeredys (Department of Stem Cell Bioengineering, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland)
• Robert Ostrowski (Department of Neurooncology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland)
• Anna Wilkaniec (Department of Cellular Signaling, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland)

   
On behalf of the Organizers, we cordially invite you to actively participate in this event.

Online registration for the conference will remain open untilSeptember 30, 2026.

For more information, please visit: ncs2026.imdik.pan.pl